Boston biotech launches organ-chip tech as FDA moves away from animal tests June 10, 2025July 9, 2025 Share More from the Blog Advancing 3D Cell Culture Models for Clinical Relevance Read More ChipChat™ Q&A: Modeling Complex Human Immune Response in the Colon Intestine-Chip Read More Emulate Liver-Chip S1 Accepted into FDA’s ISTAND Pilot Program. What’s Next? Read More Browse All